Examine Tighter Supplement Industry Regulation, Hamburg Tells Congress
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner Hamburg does not give a positive review of the current framework when Rep. Lowey questions oversight of the supplement industry during an appropriations hearing. Hamburg also says FDA needs more resources for regulating supplement production and marketing, including “snake oil salesmen.”
You may also be interested in...
Hamburg, The Atypical Commissioner, Receives Atypically Fond Farewell
Margaret Hamburg’s background in public health, as opposed to academic medicine, was off-putting to some in pharma initially, but she leaves the agency in March with high drug approval numbers, initiatives to improve the OTC monograph and switch programs and increased enforcement in the supplement manufacturing arena.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.